Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders
Pinaki Bhattacharjee, Szabolcs Dvorácskó, Océane Pointeau, Biswajit Kundu, Nicholas Rutland, Henry L. Puhl, Jie Liu, Grzegorz Godlewski, Sergio A. Hassan, Tony Jourdan, Reşat Çınar, Malliga R. Iyer
Topics & Concepts
Nitric oxide synthaseNitric oxidePharmacologyATP synthaseChemistryMedicineBiochemistryEnzymeInternal medicineCannabis and Cannabinoid ResearchNeuroscience of respiration and sleepForensic Toxicology and Drug Analysis